Total Payments
$521.94
2021 Payments
$15.00
Companies
15
Transactions
38
Medicare Patients
1,099
Medicare Billing
$157,474
Payment Breakdown by Category
Food & Beverage$521.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $521.94 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $81.74 | 6 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $63.95 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $58.21 | 4 | $0 (2018) |
| Amgen Inc. | $56.54 | 4 | $0 (2018) |
| Lilly USA, LLC | $50.96 | 4 | $0 (2017) |
| PFIZER INC. | $40.28 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $33.51 | 2 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $27.06 | 2 | $0 (2021) |
| Daiichi Sankyo Inc. | $26.39 | 2 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $17.27 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $15.00 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.00) |
| 2019 | $27.87 | 2 | PFIZER INC. ($27.87) |
| 2018 | $137.50 | 10 | Avanir Pharmaceuticals, Inc. ($17.27) |
| 2017 | $341.57 | 25 | AstraZeneca Pharmaceuticals LP ($66.57) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Gastroenterology | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: VACCINES | ||||||
| 08/31/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Endocrinology | ||||||
| 05/30/2018 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Pain Management | ||||||
| 05/14/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/18/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VACCINES | ||||||
| 04/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/06/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/12/2018 | KVK-Tech, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| 12/20/2017 | Abbott Laboratories | FreeStyle Libre Pro (Device), FreeStyle Libre Pro, FreeStyle Libre Pro | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Diabetes Care | ||||||
| 12/07/2017 | GlaxoSmithKline, LLC. | SHINGRIX (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: VACCINES | ||||||
| 11/14/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/26/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2017 | Daiichi Sankyo Inc. | Morphabond ER (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Pain Management | ||||||
| 09/22/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: VACCINE | ||||||
| 09/19/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Respiratory | ||||||
| 09/01/2017 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 102 | 157 | $130,213 | $13,461 |
| 2022 | 5 | 275 | 492 | $353,167 | $41,877 |
| 2021 | 12 | 567 | 1,020 | $682,774 | $85,412 |
| 2020 | 4 | 155 | 245 | $35,949 | $16,724 |
Total Patients
1,099
Total Services
1,914
Medicare Billing
$157,474
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 47 | $30,550 | $4,014 | 13.1% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 24 | 25 | $42,425 | $3,420 | 8.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 45 | $20,295 | $2,446 | 12.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 21 | 21 | $24,213 | $2,014 | 8.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 18 | 19 | $12,730 | $1,567 | 12.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 82 | 215 | $139,750 | $16,424 | 11.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 88 | 94 | $62,980 | $7,481 | 11.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 43 | 46 | $58,282 | $6,949 | 11.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 105 | $47,355 | $5,738 | 12.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 32 | $44,800 | $5,284 | 11.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 149 | 368 | $239,200 | $29,773 | 12.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 77 | 82 | $103,894 | $12,917 | 12.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 106 | 118 | $79,060 | $9,900 | 12.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 31 | 137 | $77,542 | $9,795 | 12.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 83 | 170 | $76,670 | $9,683 | 12.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 27 | 28 | $32,508 | $4,127 | 12.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 14 | 30 | $25,260 | $3,075 | 12.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 26 | 26 | $11,778 | $1,480 | 12.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 17 | 17 | $11,118 | $1,409 | 12.7% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 12 | 16 | $10,512 | $1,315 | 12.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 14 | 14 | $8,890 | $1,136 | 12.8% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 11 | 14 | $6,342 | $800.94 | 12.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 84 | 174 | $20,880 | $10,010 | 47.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,712 | $2,732 | 47.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 31 | 31 | $6,045 | $2,657 | 44.0% |
About Dr. Trevor Richard, MD
Dr. Trevor Richard, MD is a Hospitalist healthcare provider based in Gonzales, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588875017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Trevor Richard, MD has received a total of $521.94 in payments from pharmaceutical and medical device companies, with $15.00 received in 2021. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($521.94).
As a Medicare-enrolled provider, Richard has provided services to 1,099 Medicare beneficiaries, totaling 1,914 services with total Medicare billing of $157,474. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Gonzales, LA
- Active Since 05/25/2007
- Last Updated 12/21/2018
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1588875017
Products in Payments
- FARXIGA (Drug) $68.40
- Prolia (Biological) $56.54
- JANUVIA (Drug) $52.75
- TRULICITY (Drug) $39.06
- XARELTO (Drug) $33.51
- XIFAXAN (Drug) $27.06
- Morphabond ER (Drug) $26.39
- BREO (Drug) $25.75
- PREVNAR - 13 (Biological) $25.17
- SHINGRIX (Drug) $17.92
- NUEDEXTA (Drug) $17.27
- ELIQUIS (Drug) $15.11
- SHINGRIX (Biological) $14.54
- FLUZONE HIGH-DOSE (Drug) $14.49
- Uloric (Drug) $14.05
- FreeStyle Libre Pro (Device) $13.46
- BEVESPI AEROSPHERE (Drug) $13.34
- HUMULIN (Drug) $11.90
- ZOSTAVAX (Biological) $11.20
- Baxdela (Drug) $10.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.